| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.2M | -7.8% | +15.0% |
| R&D Expense | $19.4M | -6.8% | -30.7% |
| SG&A Expense | $9.6M | +6.2% | -16.0% |
| Operating Income | -$11.9M | -5.3% | +51.7% |
| Pre-tax Income | -$13.1M | -9.8% | +45.4% |
| Income Tax | $7K | -70.8% | +100.5% |
| Net Income | -$13.1M | -9.7% | +42.2% |
| EPS (Basic) | -$0.45 | -7.1% | +57.5% |
| EPS (Diluted) | -$0.45 | -7.1% | +57.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $34.9M | -6.7% | -42.0% |
| Accounts Receivable | $7.8M | -8.1% | +15.0% |
| Current Assets | $178.4M | -10.2% | -26.5% |
| Total Assets | $314.7M | -4.5% | -2.6% |
| Current Liabilities | $46.4M | +3.8% | +1.1% |
| Total Liabilities | $198.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$18.9M | -61.2% | — |
| Capital Expenditures | $158K | +10.5% | — |
| Investing Cash Flow | -$35.4M | +25.2% | — |
| Financing Cash Flow | $56.8M | -11.4% | — |
| Free Cash Flow | -$19.0M | -60.6% | — |
| -13.7% |
| Stockholders' Equity | $116.6M | -7.9% | +24.6% |